News

The results of the trial revealed that the tablet reduced the rate of infection with influenza by 48%.

The institute has made the development of the vaccine “one of its highest priorities.”

A new bill introduced by a group of senators aims to boost universal flu vaccine research by $1 billion over the next 5 years, as health officials continue to investigate the cause of the flu shot’s low efficacy.

High prescribing continues despite the fact that heavy use of these agents can facilitate the development of multidrug-resistant bacteria and tendon, muscle, joint, and central nervous system damage.

SMUCLA implements high-touch wipe down intervention to address the need for environmental disinfection of cancer patient care areas.

NIAID Vaccine Research Center scientists alters broadly neutralizing HIV antibody to make it last longer in the blood.

Infectious disease physicians often have to fight to garner the attention of policymakers.

Methicillin-resistant Staphylococcus aureus (MRSA) bacteremia is associated with high mortality.

The investigators concluded that 2 separate immune pathways are key players in the way in which the body deals with chlamydia: one pathway clears the bacteria, while another fuels inflammation and tissue damage.

A panel of experts in a recent symposium discuss how dental professionals can play an integral role in increasing HPV vaccination rates and decreasing HPV-related cancer.

These studies lay clear the clinical and economic toll of cytomegalovirus in the allo-HCT setting.

In case you missed them, we've compiled recalls that you should know about from this past week.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

The Michigan Department of Health and Human Services announced they are conducting an investigation of tuberculosis exposure at 3 health care facilities.

Investigators develop a statistical model predicting which bacterial strains will engraft after FMT.

FDA recommends that health care providers practice caution before prescribing clarithromycin to patients with heart disease due to potentially fatal long-term risks.

The authors of a new study sought to change the constant problem of hand hygiene adherence at their institution: here's how they did it.

PrEP does not have to be taken daily to be effective, but consistency and a strong support system are key.

A recent study finds a potential link between cannabis use and possible beneficial reduction in systemic inflammation and immune activation in ART-treated HIV patients.

The CDC’s Advisory Committee on Immunization Practices has included HEPLISAV-B on its list of recommended products for use to vaccinate adults against hepatitis B.

The Iowa Department of Health releases case counts associated with a Salmonella outbreak linked with chicken salad sold at Fareway stores.

While a new report has found that the flu vaccine has been just 36% effective this year, a recent study suggests that history of exposure to flu may, in part, be to blame.

One agency estimates that at least 50% of all antibiotic prescriptions written in the United States do not fall under currently accepted practice guidelines.

The CDC have launched an investigation into a multistate outbreak of Salmonella I 4,[5],12:b:- infections that has been linked with opioid substitute kratom.

Mylan NV's new drug application for its combo regimen of dolutegravir, emtricitabine, and tenofovir alafenamide, received tentative approval from the US Food and Drug Administration under the President's Emergency Plan for AIDS Relief (PEPFAR).

A new study announced by the National Institute of Allergy and Infectious Diseases may help cut the number of antibiotics unnecessarily prescribed for viral lower respiratory tract infections.

A molecule capable of clearing HSV-1 infection in the cells of the cornea could be a promising potential option for those who have developed resistance to current drugs.

A recent CDC report finds those between 15 and 44 years of age are significantly more likely to have never been tested for HIV.

Massive vaccination campaigns launched in Brazil and Nigeria strive to quell ongoing outbreaks.

A recent report documents the first recorded case of a human infestation with the cattle eyeworm Thelazia gulosa.